Catalyst Wire Dossier Catalyst Wire Dossier

5-Azacitidine

azacitidine · Celgene/BMS
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for 5-Azacitidine, covering 2013-12-18 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy [Phase 2]

See pricing